Close

Regenxbio Inc. (RGNX) PT Raised to $65 at Raymond James

February 11, 2021 4:00 PM EST Send to a Friend
Raymond James analyst Dane Leone raised the price target on Regenxbio Inc. (NASDAQ: RGNX) to $65.00 (from $60.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login